Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Cardiff Oncology, Inc. (TROV) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $8.56 Metrics
OS: 44.7 M
Market cap: $382 M
Net cash: $118 M $2.65 per share
EV: $264 M

 
TTM Valuation
EBITDA
EBIT
EPS

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
Revenues0.40.40.40.20.40.50.40.3
            Revenue growth7.5%-1.9%49.6%-35.3%-25.1%32.6%21.8%11.6%
Cost of goods sold0.00.00.0-16.90.61.81.70.6
Gross profit0.40.40.417.2-0.2-1.3-1.3-0.3
            Gross margin100.0%100.0%100.0%7018.6%-57.9%-258.4%-354.1%-101.1%
Selling, general and administrative13.211.88.25.88.014.2  
Sales and marketing      11.56.4
Research and development27.117.411.211.28.27.915.010.6
General and administrative      11.57.9
EBIT-39.9-28.9-19.1-16.7-16.4-23.4-39.4-25.3
            EBIT margin-10337.3%-8037.6%-5214.8%-6817.8%-4331.9%-4634.2%-10327.5%-8079.5%
Pre-tax income-38.7-28.3-19.3-16.4-16.5-24.9-39.2-27.5
Income taxes0.00.00.00.00.00.00.00.0
            Tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income-38.7-28.3-22.6-16.7-19.3-24.9-39.2-27.5
            Net margin-10033.2%-7887.2%-6174.3%-6829.3%-5089.5%-4932.9%-10294.1%-8789.7%
 
Diluted EPS($0.89)($0.73)($1.08)($2.80)($8.26)($51.76)($1.30)($1.04)
Shares outstanding (diluted)43.639.020.96.02.30.530.326.5
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy